PHARMAGEN, INC. Proceeds from Convertible Debt
PHARMAGEN, INC. reported Proceeds from Convertible Debt of $755.50 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2014-03-31
- PHARMAGEN, INC. proceeds from convertible debt for the quarter ending 2013-12-31 was $0.00.
- PHARMAGEN, INC. proceeds from convertible debt for the quarter ending 2013-09-30 was $92.50K.
- PHARMAGEN, INC. proceeds from convertible debt for the quarter ending 2012-12-31 was $0.00.
- PHARMAGEN, INC. proceeds from convertible debt for the quarter ending 2012-09-30 was $0.00.
- PHARMAGEN, INC. proceeds from convertible debt for fiscal 2013 was $755.50K, a 47.90% decline from fiscal 2012.
- PHARMAGEN, INC. proceeds from convertible debt for fiscal 2012 was $1.45M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $92.50K derived: sum of 2 quarters · filed 2014-03-31 | $755.50K 10-K · filed 2014-03-31 | |
| 2013-09-30 | $92.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $755.50K 10-Q · filed 2013-11-14 | ||
| 2013-06-30 | $663.00K 10-Q · filed 2013-08-14 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $1.05M derived: sum of 3 quarters · filed 2014-03-31 | $1.45M 10-K · filed 2014-03-31 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $1.05M derived: sum of 2 quarters · filed 2013-11-14 | $1.45M 10-Q · filed 2013-11-14 | |
| 2012-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $1.45M 10-Q · filed 2013-08-14 | ||
| 2012-03-31 | $400.00K 10-Q · filed 2013-05-15 | |||
| 2011-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-14 | $0.00 10-Q/A · filed 2012-09-14 | ||
| 2011-03-31 | $0.00 10-Q · filed 2012-06-11 |